GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BlackRock Health Sciences Trust II (NYSE:BMEZ) » Definitions » 5-Year Yield-on-Cost %

BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) 5-Year Yield-on-Cost %

: 9.44 (As of Today)
View and export this data going back to 1990. Start your Free Trial

BlackRock Health Sciences Trust II's yield on cost for the quarter that ended in Dec. 2023 was 9.44.


The historical rank and industry rank for BlackRock Health Sciences Trust II's 5-Year Yield-on-Cost % or its related term are showing as below:

BMEZ' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 6.68   Med: 10.6   Max: 13.12
Current: 9.44

During the past 4 years, BlackRock Health Sciences Trust II's highest Yield on Cost was 13.12. The lowest was 6.68. And the median was 10.60.


BMEZ's 5-Year Yield-on-Cost % is ranked better than
72.37% of 1216 companies
in the Asset Management industry
Industry Median: 6.05 vs BMEZ: 9.44
Competitive Comparison

For the Asset Management subindustry, BlackRock Health Sciences Trust II's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BlackRock Health Sciences Trust II 5-Year Yield-on-Cost % Distribution

For the Asset Management industry and Financial Services sector, BlackRock Health Sciences Trust II's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where BlackRock Health Sciences Trust II's 5-Year Yield-on-Cost % falls into.


BlackRock Health Sciences Trust II 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of BlackRock Health Sciences Trust II is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

BlackRock Health Sciences Trust II  (NYSE:BMEZ) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

BlackRock Health Sciences Trust II 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of BlackRock Health Sciences Trust II's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BlackRock Health Sciences Trust II (NYSE:BMEZ) » Definitions » 5-Year Yield-on-Cost %
Comparable Companies
GAB EVT BIGZ BTT NAC ECAT BDJ VRTS RVT ETV BLK BX OSTO:INVE A KKR TSX:BN APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
Website
https://www.blackrock.com
BlackRock Health Sciences Trust II is a closed-end management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Executives
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Frank Fabozzi director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert Glenn Hubbard director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212